> News > Company News

Warm congratulations!The Antigen Rapid Detection Kit (colloidal gold method) produced by Babio has been awarded the White List of Germany, France and Spain and the Certificate of free sale in Vietnam

2022-07-09

Good news!Recently, Antigen Rapid Detection Kit (Colloidal Gold Method) independently developed and produced by Babio (stock code: 830774) has been granted the Certificate of free sale in Vietnam and the Hague certification. Among them, the self-tested rapid test kit has been whitelisted in Germany, France and Spain respectively.

This fully demonstrates the excellent performance of Babio products and the solid trust of consumers, and will also bring a new leap for the overseas layout of Babio. At present, the epidemic situation is still severe. The nucleic acid test reagents of Babio will continue to contribute to the rapid screening of novel Coronavirus and to the epidemic prevention and control and medical and health construction in Europe, the United States and Southeast Asia.

About Babio biology

Established in 2003, Jinan Biotechnology Co., Ltd. is a high-tech enterprise specializing in the r&d, production and sales of in vitro diagnostic reagents. On May 30, 2014, the company was successfully listed on the New Third Board (stock name: B A Bio, stock code: 830774), becoming one of the earliest listed companies of in vitro diagnostic reagents after the stock expansion of the New Third Board in China. In June 2021, Babio officially entered the innovation layer of neeQ.

The products mainly involve: Virus transport medium series, the series of sterile swabs, antigen/antibody rapid diagnostic test series, the series of reagent kit when microbial reagents/check, inspection of department of gynaecology series, the series of biochemical reagents, medical apparatus and instruments/robot series, the colloid other female pregnancy test series, helicobacter pylori Igg/igm test kit, mycoplasma pneumoniae igm test kits, rotavirus Virus antigen detection kit and other gold series. After more than ten years of technology accumulation, innovation and equipment improvement, Babio Biological has become a deep cultivator in the field of microbiology, is one of the few domestic microbial reagent manufacturers with two automatic production lines. At the same time, with the outbreak of the global epidemic in 2020, with years of professional research, quality management ability, fully automated production equipment and other advantages during the epidemic, Products sold well in Europe, America, Southeast Asia and other regions, playing an important role in virus sampling and detection products.

Previous:Helicobacter pylori (H.pylori) IgG/ IgM Test Kit Test Procedure

Next: Babio's three monkeypox virus detection products have also won the CE certification of the European Union